Management of Advanced HER2+ Breast Cancer - Episode 5

Investigational Agents, Clinical Trials for Advanced HER2+ Breast Cancer

,

Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss novel agents in the pipeline for patients with advanced HER2-positive breast cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Current Prognosis for Advanced or Metastatic HER2+ Breast Cancer
    EP. 2: Optimal Management Strategies in Advanced HER2+ Breast Cancer
    EP. 3: Treatment Decisions in Advanced HER2+ Breast Cancer With CNS Metastases
    EP. 4: Frequent AEs and Management Approaches for Advanced HER2+ Breast Cancer
    Now Viewing
    EP. 5: Investigational Agents, Clinical Trials for Advanced HER2+ Breast Cancer
    x